T1	Participants 153 235	individuals with serious mental illness (SMI) receiving antipsychotic drug therapy
T2	Participants 479 512	individuals with SMI over 8 weeks
T3	Participants 521 554	30 individuals (BMI â‰¥ 28 kg/m(2))
T4	Participants 1331 1372	patients taking antipsychotic medications
